Through our network of 26,000 people in 1,000 laboratories and offices in 100 countries, Intertek provides quality and safety solutions to a wide range of industries around the world. Learn more...
A career with Intertek offers rewarding opportunities to help companies around the world develop products that are used safely by millions of people every day. Learn more...
A growing number of vaccines today are based on well-defined materials, including vaccines based on purified protein antigens of natural origin or produced by rDNA technology, polysaccharides, semi-synthetic poly- or oligosaccharide-protein conjugates and novel nucleic acid constructs. These products can raise challenges for characterisation. Through the application of a comprehensive suite of methods currently in use for evaluating carbohydrate, lipopolysaccharide, lipid, protein, glycoprotein, and lipoprotein components of vaccines, Intertek can provide support for vaccine manufacturers and researchers through out the vaccine development process.
Vaccine Analysis services include:
Request more information to see how Intertek can help your organization with Vaccine GLP and cGMP Analysis.
